Circulating Tumor Cell (CTC) Testing Market Size, Industry Share Forecast 2028

According to Precision Business Insights (PBI) latest report, the global circulating tumor cell (ctc) testing market size was valued at USD 9.4 billion in 2021 and is expected to reach USD 16.4 billion by 2028, at a CAGR of 11.7% during 2022-2028. Circulating tumor cells (CTC) are the kind of cells that are typically located in the lymphatics or vasculature of a tumor and are transported throughout the body via blood circulation. The purpose of CTC tests is to assist the oncologist in determining whether the patient has metastatic colorectal, prostate, or breast cancer.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/circulating-tumor-cell-ctc-testing-market/

The Circulating Tumor Cell (CTC) Testing Market Growth Factors:
One of the key factors anticipated to accelerate the growth as well as the demand of the circulating tumor cells (CTC) market is the increase in awareness regarding the use of CTC in cancer care. Over the forecast period of 2021 to 2028, it is also anticipated that the increasing preference of people in developing economies for hospitals over alternative medical facilities due to affordability will boost to the growth of the global market. A sophisticated healthcare system and the rising prevalence of multiple chromosomal abnormalities syndromes are also projected to support market expansion. Additionally, the market for circulating tumor cells (CTCs) is anticipated to rise as a result of the growing prevalence of preventative medicine and the quick advancement of cluster chip technology. However, the market for circulating tumor cells (CTC) is predicted to develop slowly due to low consumer knowledge of advanced CTC technologies and high CTC costs, whilst the market for CTC may face difficulties as point-of-care testing becomes more commonplace.

The Circulating Tumor Cell (CTC) Market Segmentation:
The Circulating Tumor Cell (CTC) Testing Market on the basis of Technology, the market is fragmented into CTC detection (Functional in-vitro cell invasion assay, Molecular (RNA) based technologies, Xenotransplantation models, Immunocytochemical technologies, EPISPOT functional in-vitro cell culture), (CTC Enrichment (Microchips, In-vivo positive selection, Single spiral micro channel, Ex-vivo positive selection, Negative selection), CTC Analysis). Based on Application, the market is categorized into EMT biomarkers development, Cancer stem cell research, Tumorigenesis research, and Others. Based on End-user, the market is divided into Diagnostic Centers, Hospitals, and Ambulatory Surgical Centers.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=22263

The Circulating Tumor Cell (CTC) Market Regional Analysis:
Due to its well-established healthcare system and the incorporation of cutting-edge diagnostic technology, North America dominated the industry with the biggest market share. Because cancer disorders are becoming more common in the U.S., there is an increasing demand for circulating tumor cells. To increase their presence in the market, these businesses are implementing a number of different techniques.

Key players in the circulating tumor cell market report are Fluxion Biosciences (U.S.), Clearbridge BioMedics (Singapore), Adnagen (Germany), Apocell (U.S.), Advanced Cell Diagnostics (U.S.), Cynvenio Biosystems (U.S.)

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.